AffyMax.com
About AffyMax.com
Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. The company’s product candidate, Hematide™, is currently in Phase 3 trials for the treatment of anemia associated with chronic renal failure. Anemia is a serious condition in which blood is deficient in red blood cells and hemoglobin.
